Education
About Us
Working with TipRanks
Follow Us
Luye Pharma Group Ltd. (HK:2186)
:2186
2186 Stock Chart & Stats
HK$2.83
HK$0.04(1.95%)
At close: 4:00 PM EST
HK$2.83
HK$0.04(1.95%)
Day’s Range― - ―
52-Week RangeHK$1.67 - HK$4.49
Previous CloseN/A
Volume7.60M
Average Volume (3M)38.67M
Market Cap
HK$11.08B
Enterprise ValueHK$16.36B
Total Cash (Recent Filing)HK$8.83B
Total Debt (Recent Filing)HK$11.87B
Price to Earnings (P/E)24.9
Beta0.95
Next Earnings
Apr 01, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding3,994,515,900
10 Day Avg. Volume34,399,920
30 Day Avg. Volume38,673,367
Financial Highlights & Ratios
PEG Ratio-2.27
Price to Book (P/B)0.54
Price to Sales (P/S)1.26
P/FCF Ratio-4.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Luye Pharma Group News
2186 FAQ
What was Luye Pharma Group Ltd.’s price range in the past 12 months?
Luye Pharma Group Ltd. lowest stock price was HK$1.67 and its highest was HK$4.49 in the past 12 months.
What is Luye Pharma Group Ltd.’s market cap?
Luye Pharma Group Ltd.’s market cap is HK$11.08B.
When is Luye Pharma Group Ltd.’s upcoming earnings report date?
Luye Pharma Group Ltd.’s upcoming earnings report date is Apr 01, 2026 which is in 104 days.
How were Luye Pharma Group Ltd.’s earnings last quarter?
Luye Pharma Group Ltd. released its earnings results on Aug 28, 2025. The company reported HK$0.091 earnings per share for the quarter, beating the consensus estimate of HK$0.077 by HK$0.014.
Is Luye Pharma Group Ltd. overvalued?
According to Wall Street analysts Luye Pharma Group Ltd.’s price is currently Overvalued.
Does Luye Pharma Group Ltd. pay dividends?
Luye Pharma Group Ltd. pays a Annually dividend of HK$0.06 which represents an annual dividend yield of N/A. See more information on Luye Pharma Group Ltd. dividends here
What is Luye Pharma Group Ltd.’s EPS estimate?
Luye Pharma Group Ltd.’s EPS estimate is 0.09.
How many shares outstanding does Luye Pharma Group Ltd. have?
Luye Pharma Group Ltd. has 3,994,515,900 shares outstanding.
What happened to Luye Pharma Group Ltd.’s price movement after its last earnings report?
Luye Pharma Group Ltd. reported an EPS of HK$0.091 in its last earnings report, beating expectations of HK$0.077. Following the earnings report the stock price went down -3.746%.
Which hedge fund is a major shareholder of Luye Pharma Group Ltd.?
Currently, no hedge funds are holding shares in HK:2186
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Luye Pharma Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.45%
12-Months-Change
Fundamentals
Return on Equity
2.85%
Trailing 12-Months
Asset Growth
19.42%
Trailing 12-Months
Company Description
Luye Pharma Group Ltd.
Luye Pharma Group (2186) is a global biopharmaceutical company headquartered in China, specializing in the research, development, manufacturing, and commercialization of innovative drugs. The company focuses primarily on therapeutic areas such as oncology, central nervous system disorders, and anesthetics, and has a diverse portfolio that includes both proprietary products and generic medications. Luye Pharma is committed to enhancing patient outcomes through advanced drug delivery systems and formulations.
Technical Analysis
CSPC Pharmaceutical Group
―
Sihuan Pharmaceutical Holdings Group
―
Consun Pharmaceutical Group Ltd.
―
―
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
Options Prices
Currently, No data available
---